Clinical trial
To Determine if Chromium Nicotinate Supplementation Will Improve Insulin…
NCT00152893 · Johane Allard, Other · Completed
Key facts
| NCT number | NCT00152893 |
|---|---|
| Title | To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities |
| Official title | The Effects of Chromium Supplementation on Glucose and Lipid Metabolism in Patients With HIV Infection |
| Lead sponsor | Johane Allard, Other |
| Collaborators | Canadian Foundation for AIDS Research (CANFAR) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | chromium nicotinate, Placebo |
| Enrollment | 52 |
| Start date | Aug 1, 2002 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 9, 2005 |
| Last update posted | Jul 19, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: